Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Genetown symbols : Gsk save search
PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial
Published: 2023-03-30 (Crawled : 15:20) - biospace.com/
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 0.0%
H: 0.65%
C: 0.6%
collaboration trial nash
Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: -12.81%
H: 8.43%
C: 5.21%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -8.67%
H: 2.89%
C: 2.14%
FULC | $7.31 -1.75% 140K
|
Health Technology
|
| O: -10.82%
H: 17.27%
C: 9.39%
therapeutics update results
Viridian Therapeutics Appoints Carrie Melvin as Chief Operating Officer
Published: 2022-06-23 (Crawled : 12:00) - biospace.com/
VRDN | $13.2 -7.37% 420K
|
Health Care and Social Assistan...
|
| O: 2.45%
H: 7.18%
C: 3.81%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 1.31%
H: 0.59%
C: 0.54%
XFOR | $1.245 1.22% 1.2M
|
Health Technology
|
| O: 4.69%
H: 3.37%
C: -4.48%
KURA | News | $18.76 0.16% 340K
|
Health Technology
|
| O: 0.44%
H: 7.19%
C: 6.63%
therapeutics
Oak Hill Bio Announces Formation of Board of Directors
Published: 2022-04-12 (Crawled : 13:00) - biospace.com/
TAK | News | $13.265 -0.86% 540K
|
Health Technology
|
| O: 0.07%
H: 0.47%
C: -0.4%
NVO | News | $126.19 -1.91% 2.6M
|
Health Technology
|
| O: -3.41%
H: 1.22%
C: 0.49%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
Oak Hill Bio Launches With Pipeline and Senior Leadership From Takeda
Published: 2022-02-01 (Crawled : 12:30) - biospace.com/
TAK | News | $13.265 -0.86% 540K
|
Health Technology
|
| O: 0.07%
H: 1.53%
C: 1.32%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 0.45%
H: 0.53%
C: 0.42%
OncXerna Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
Published: 2021-08-17 (Crawled : 12:00) - biospace.com/
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -0.19%
H: 0.86%
C: 0.79%
therapeutics
Vertex Appoints Stuart A. Arbuckle as Chief Operating Officer
Published: 2021-08-04 (Crawled : 13:15) - biospace.com/
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 0.05%
H: 0.39%
C: -0.39%
VRTX | $401.58 -0.82% 430K
|
Health Technology
|
| O: -0.02%
H: 1.0%
C: -0.2%
CureVac Appoints Klaus Edvardsen as Chief Development Officer
Published: 2021-06-02 (Crawled : 12:00) - biospace.com/
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 0.13%
H: 0.44%
C: -0.03%
GMAB | News | $28.46 -0.35% 310K
|
Health Technology
|
| O: 0.0%
H: 1.04%
C: 0.95%
CVAC | $2.41 -7.31% 810K
|
Health Technology
|
| O: -0.26%
H: 6.12%
C: 6.12%
Swift Fall From Grace Continues for Former COVID-19 Vaccine Czar Slaoui
Published: 2021-03-25 (Crawled : 15:15) - biospace.com/
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -0.2%
H: 0.81%
C: 0.75%
covid vaccine trace covid-19
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
RILY | $30.01 38.17% 11M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.